QSMetric Potential Indications [Context] Iron, iron accumulation and ferroptosis Dr ROCHE Stéphane Background to our series of articles “Biomedical applications[…]
Read moreStephane Roche becomes CEO of Ventio Technical Director for the past 2 years, Dr Stephane Roche took up his new[…]
Read moreMiguel Guevara1, Davy Cam4, Jacques Badagbon4, Stéphane Roche4, Michel Bottlaender3, Yann Cointepas1,2, Jean-François Mangin1,2, Ludovic de Rochefort4 and Alexandre Vignaud1,2[…]
Read moreQSM4SENIOR: Quantitative susceptibility mapping in the aging of the healthy brain. Miguel Guevara1,2, Davy Cam3, Jacques Badagbon3, Michel Bottlaender2, Yann[…]
Read moreDecreased sAβPPβ, Aβ38, and Aβ40 Cerebrospinal Fluid Levels in Frontotemporal Dementia Gabelle, Audrey, Roche, Stéphane, Gény, Christian, Bennys, Karim, Labauge,[…]
Read moreCorrelations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in human cerebrospinal fluid Audrey Gabelle,[…]
Read morePreanalytical guidelines for clinical proteomics investigation of biological fluids S Lehmann, S. Roche, Y. Allory, A. Barthelaix, J.-L. Beaudeux, F.[…]
Read moreLes marqueurs biologiques protéiques du liquide céphalorachidien : caractéristiques et implications cliniques dans les démences A Gabelle, S. Roche &[…]
Read moreAuto-antibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal-fluid. Stéphane Roche, Yves Dauvilliers, Laurent Tiers, Carine Couderc,[…]
Read moreClinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers Stéphane Roche, Audrey Gabelle & Sylvain Lehmann Proteomics[…]
Read more